No abstract

To investigate the possibility that an autoimmune mechanism may play a role in the hereditary neuropathy Charcot‐Marie‐Tooth type 1A (CMT1A), sera were analysed by Western blot for anti‐peripheral myelin protein 22 (PMP22) autoantibodies. These sera were compared with sera from patients with CMT type 2 (CMT2), acquired peripheral neuropathies such as chronic inflammatory demyelinating neuropathy (CIDP), anti‐MAG IgM neuropathy, Miller‐Fisher syndrome (MFS), diabetic neuropathy and with control blood donors. Anti‐PMP22 positive sera were detected in 70% of patients with CMT1 and unexpectedly in 60% of patients with CMT2. Interestingly, 44% of the patients with other peripheral neuropathies and 23% of the apparently healthy controls showed also anti‐PMP22 antibody reactivity. Immunohistochemical analysis of the human anti‐PMP22 antisera on healthy sural nerve sections and on PMP22‐expressing COS cells revealed that these sera did not recognize endogenous PMP22. Our results indicate that anti‐PMP22 autoantibodies are found in sera of patients with different types of peripheral neuropathies, but their role in the pathogenesis of these diseases remains to be determined.